Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals

School of Medicine, Indiana University, Indianapolis, Indiana, USA Boehringer Ingelheim International GmbH, Ingelheim, Germany Vth Department of Medicine, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany Centre for Nephrology, University College London, London, UK Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany Department of Nephrology, Faculty of Medicine, Technical University Munich, Munich, Germany Division of Nephrology, Würzburg University Clinic, Würzburg, Germany